Retinoid differentiation therapy in promyelocytic leukemia

FASEB Journal

Volumn 10, Issue 9, 1996, Pages 1025-1030

  Chomienne, Christine ^a   Fenaux, Pierre ^b   Degos, Laurent ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Centre Hospitalier Universitaire   (France)

Author keywords

acute myeloid leukemia; APL; ATRA therapy; RA efficacy; RAR

Indexed keywords

ALITRETINOIN; ANTHRACYCLINE DERIVATIVE; CYTARABINE; CYTOKINE; DAUNORUBICIN; RECEPTOR SUBUNIT; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; TAMIBAROTENE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; BLAST CELL CRISIS; BLOOD CLOTTING DISORDER; CHROMOSOME 17; CHROMOSOME TRANSLOCATION 15; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; FEVER; HUMAN; HUMAN CELL; HYPOTENSION; KIDNEY FAILURE; LEG EDEMA; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; PLEURA EFFUSION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; THROMBOEMBOLISM; WEIGHT GAIN;

EID: 0029838662     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.10.9.8801163     Document Type: Review

References (67)

1. Bennett, J. M., Calovsky, D., Daniel, M. T., Flandrin, G., Galton, D., Gralnick, M., and Sultan, C. (1976) Proposals for the classification of the acute leukemias. Br. J. Haematol. 33, 451-458
2. Larson, R. A., Kondo, K., Vardiman, J. W., Butler, A. R. E., Colomb, H. M., and Rowley, J. D. (1984) Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am. J. Med. 76, 827-841
3. de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., and Dejean, A. (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684
4. Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R., Frankel, S., Dmitrovsky, E., and Evans, R. (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674
5. Dombret, H., Sutton, L., Duarte, M., Daniel, M. T., Leblond, V., Castaigne, S., and Degos, L. (1992) Combined therapy with all-trans retinoio acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. Leukemia 6, 1237-1242
6. Huang, M. E., Yu-Chen, Y., Shu-Rong, C., Lu, M. X., Zhoa, L., Gu, L. J., and Wang, Z. Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567-572
7. Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M. T., Fenaux, P., Castaigne, S., and Degos, L. (1990) All trans retinoic acid in promyelocytic leukemias. II. In vitro studies structure function relationship. Blood 76, 1710-1717
8. Castaigne, S., Chomienne, C., Daniel, M. T., Berger, R., Fenaux, P., and Degos, L. (1990) All-trans retinoic acid as a differentiating therapy for acute promyelocytic leukemias. I. Clinical results. Blood 76, 1704-1709
9. Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P., Donti, E., Biondi, A., Lo Coco, F., and Pellici, P. G. (1994) Review: acute promyelocytic leukemia: from genetics to treatment. Blood 83, 10-25
10. Warrell, R. P., Jr., de Thé, H., Wang, Z. Y., and Degos, L. (1993) Acute promyelocytic leukemia. N. Engl. J. Med. 329, 177-183
11. Castaigne, S., Balitrand, N., de Thé, H., Dejean, A., Degos, L., and Chomienne, C. (1992) A PML/RARα fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood. 79, 3110-3115
12. Miller, W. H., Levine, K., DeBlasio, A., Frankel, S. R., Dmitrovsky, E., and Warrell, R. P. (1993) Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for PML-RARα fusion mRNA. Blood 82, 1689-1694
13. Diverio, D., Pandolfi, P .P., Rossi, V., Biondi, A., Pelicci, P. G., and LoCoco, F. (1994) Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR. Leukemia 8, 1105-1107
14. Licht J. D, Chomienne, C., Goy, A., Chen, A., Scott, A. A, Head, D. R., Michaux, J. L., Wu, Y., Deblasio, A., and Miller, W. H. (1995) Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85, 1083-1094
15. Guidez, F., Huang, W., Tong, J. H., Dubois, C., Balitrand, N., Waxman, S., Michaux, J. L., Martiat, P., Degos, L., Chen, Z., and Chomienne, C. (1994) Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RARα patient. Leukemia 8, 312-317
16. Redner, R. L., Rush, E. A., Faas, S., Rudert, W. A., and Corey, S. J. (1996) The t(5;17) variant of acute promyelocytic leukemis expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87, 882-886
17. Gratas, C., Menot, M. L., Dresch, C., and Chomienne, C. (1993) Retinoic acid supports granulocytic but not erythroid differentiation of myetoid progenitors in normal bone marrow cells. Leukemia 7, 1156-1162
18. Van Bockstaele, D. R., Lenjou, M., Snoeck, H. W., Lardon, F., Stryckmans, P., and Peetermans, M. E. (1993) Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells. Ann. Haematol. 66, 61-66
19. Collins S. J., Roberton K. A., and Mueller, L. (1990) Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RARα). Mol. Cell. Biol. 10, 2154-2163
20. Rousselot, P., Hardas, B., Castaigne, S., Dejean, A., de Thé, H., Degos, L., Farzaneh, F., and Chomienne, C. (1994) The PML-RARα gene product of the t(15:17) translocation inhibits retinoic acid induced granulocytic differentiation. Oncogene 9, 545-551
21. Chen, Z., Guidez, F., Rousselot, P., Agadir, A., Chen, S. J., Wang, Z. Y., Degos, L., Waxman, S., Zelent, A., and Chomienne, C. (1994) PLZF-RAR fusion protein generated from the translocation t(11;17)(q23;q21) displays altered transactivation properties against the wild-type retinoic acid receptors. Proc. Natl. Acad. Sci. USA 91, 1178-1182
22. Koken, M. H. M., Puvion-Dutilleuil, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C., Degos, L., Puvion, E., and de Thé, H. (1994) The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073-1083
23. Crignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Crignani, F., Peschle, C., Nicoletti, L., and Pellici P. G. (1993) The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74, 423-431
24. Grignani, F., Testa, U., Mascuilli, R., Mariani, G., Fagioli, M., Barberi, T., Peschle, C., and Pelicci, P. G. (1995) Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells. Cancer Res. 55, 440-443
25. Turhan, A. G., Lemoine, F. M., Debert, C., Bonnet, M. L., Baillou, C., Picard, F., Macintyre, E. A., and Varet, B. (1995) Highly purified primitive hematopoietic stem cells are PML-RARα negative and generate monoclonal progenitors in acute promyelocytic leukemia. Blood 85, 2154-2161
26. Seale, J, Delva L., Renesto P., Balitrand, N., Dombret, H., Scrobohaci, M. L., Degos. L., Paul, P., and Chomienne, C. (1996) All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia. Leukemia 10, 95-101
27. De Gentile, A., Toubert, M. E., Dubois, C., Krawice, I., Schlageter, M. H., Balitrand, N., Castaigne, S., Degos, L., Rain, J. D., Najean, Y., and Chomienne, C. (1994) Induction of high-affinity CM-CSF receptor during all- trans retinoic acid treatment of acute promyelocylic leukemia Leukemia 8, 1758-1762
28. Dubois, C., Schlageter, M. H., De Gentile, A., Guidez, F., Balitrand, N., Toubert, M. E., Krawice, I., Fenaux, P., Castaigne, S., Najean, Y., Degos, L., and Chomienne, C. (1994) Modulation of 11-6 and 11-1β and G-CSF secretion by all-trans retinoic acid in acute promyelocylic leukemia Leukemia 8, 1750-1757
29. Martin, S. J., Bradley, J. G., and Cotter, T. G. (1990) HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol. 79, 448-453
30. Tosi, P., Visani, G., Gibellini, D., Zauli, G., Ottoviani, E., Cenacchi, A., Gamberi, B., Manfrois, S., Marchisio M., and Turas, S. (1994) All-trans retinoic acid and induction of apoptosis in acute promyelocylic leukemia cells. Leukemia & Lymphoma 14, 503-507
31. Calabresse, C., Barbey, S., Venturini, L., Balitrand, N., Degos, L., Fenaux, P., and Chomienne, C. (1995) In vitro treatment with retinoids or the lopoisomerase inhibitor, VP16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cells. Leukemia 9, 2049-2057
32. Dubois, C., Schlageter, M. H., De Gentile, A., Guidez, F., Balitrand, N., Toubert, M. E., Krawice, I., Fenaux, P., Castaigne, S., Najean, Y., Degos, L., and Chomienne, C. (1991) Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic leukemia. Blood 83, 3264-3270
33. Chambon, P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954
34. Agadir, A., Cornic, M., Jerome, M., Menot, M. L., Cambier, N., Gaub, M. P., Gourmel, B., Lefebvre, P., Degos L., and Chomienne, C. (1995) Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RARα protein modulation. BBRC 213, 112-122
35. Chomienne, C., Balitrand, N., Ballerini, P., Castaigne, S., de Thé, H., and Degos, L. (1991) All-trans retinoic acid modulates the retinoic acid receptor alpha in promyelocylic cells. J. Clin. Invest. 88, 2150-2154
36. Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B., Lanotte, M., Berger, R., and Chambon, P. (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J. 11, 629-642
37. Lefebvre, P., Thomas, G., Gourmel, B., Dreux, C., Castaigne, S., and Chomienne, C. (1991) Pharmacokinetics of all-trans RA in patients with acute promyelocylic. Leukemia 5, 1054-1058
38. Muindi, J., Frazkel, S. R., Miller, W. H., Jakubowski, A., Scheinberg, D. A., Young, C. W., and Dimitrovsky, E. (1992) Continuous treatment with all-trans RA progressively decreases plasma drug concentrations: implications for relapse and resistance in acute promyelocytic leukemia. Blood 79, 299-303
39. Agadir, A., Cornic, C., Lefebvre, P., Gourmel, B., Balitrand, N., Degos, L., and Chomienne, C. (1995) Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: Evidence for its role in retinoic acid efficacity. Leukemia 9, 139-145
40. Agadir, A., Cornic, M., Lefebvre, P., Gourmel, B., Jerome, M., Degos, L., Fenaux, P., and Chomienne, C. (1995) All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: Intracellular concentrations and biologic response relationship. J. Clin. Oncol. 13, 2517-2523
41. Napoli, J. L. (1996) Retinoic acid biosynthesis and metabolism. FASEB J. 10, 993-1001
42. Delva, L., Cornic, M., Balitrand, N., Guidez, F., Miclea, J. M., Delmer, A., Teillet, F., Fenaux, P., Castaigne, S., Degos, L., and Chomienne, C. (1993) Resistance to all-trans retinoic acid therapy in relapsing acute promyelocytic leukemia. Blood 82, 2175-2181
43. Cornic, M., Delva, L., Castaigne, S., Balitrand, N., Degos, L., and Chomienne, C. (1994) In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remisssion induction by ATRA in acute promyelocytic leukemia. Leukemia 8, 914-917
44. Warrell, R. P., Frankel, S. R., Miller, W., Itri, L., Andreeff, M., Jabukowski, A., Gabrilove, J., Gordon, M. S., and Dmitrovsky, E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324, 1385-1393
45. Warrell, R. P., Maslak, P., Eardley, A., Heller, G., Miller, W. H., and Frankel, S. R. (1994) Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia 8, 926-933
46. Kanamaru, A., Takemoto, Y., Tanimoto, M., Murakami, H., Asou, N., Kobayashi, T., Kuriyama, K., Ohmoto E., Sakamaki, H., Tsubaki, K., Hiraoka, A., Yamada, O., Oh, H., Saito, K., Matsuda, S., Minato, K., Ueda, T., and Ohno, R. (1995) all-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85, 1202-1206
47. Wiley, J. S., and Firkin, F. C. (1995) Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocylic leukemia. Leukemia 9, 774-778
48. Fenaux, P., Castaigne, S., Dombret, H., Archimbaud, E., Duarte, M., Morel, P., Lamy, T., Tilly, H., Guerci, A., Maloisel, F., Bordessoule, D., Sadoun, A., Tiberghien, P., Fegueux, N., Daniel, M. T., Chomienne, C., and Degos, L. (1992) All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood 80, 2176-2181
49. Fenaux, P., Wattel, E., Archimbaud, E., Sanz, M., Hecquet, B., Guerci, A., Link,. H, Fegueux, N., Fey, M., Castaigne, S., and Degos, L. (1994) Prolonged follow up confirms that all-trans retinoic acid (ATRA) followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia (APL). Blood 84, 666-667
50. Fenaux, P., Le Deley, M. C., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M. T., Bowen, D., Huebner, G., Bauters, F., Fegueux, N., Fey, M., Sanz, M., Lowenberg, B., Maloisel, F., Auzanneau, G., Sadoun, A., Gardin, C., Bastion, Y., Ganser, A., Jacky, E., Dombret, H., Chastang, C., and Degos, L. (1993) Effect of all trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 82, 3241-3249
51. Fenaux, P., Chastang, C., Chomienne, C., and Degos, L. (1994) Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. Lancet 343, 1033
52. Degos, L., Dombret, H., Chomienne, C., Daniel, M. T., Miclea, J. M., Chastang, C., Castaigne, S., and Fenaux, P. (1995) All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocylic leukemia. Blood 85, 2643-2653
53. Degos, L., Chomienne, C., Daniel, M. T., Berger, R., Dombret, H., Fenaux, P., and Castaigne, S. (1990) Treatment of first relapse in acute promyelocytic leukaemia with all trans retinoic acid. Lancet 2, 1440-1441
54. Tallman, M. S., Andersen, J., Schiffer, C. A., Appelbaum, F, R., Feusner, J. E., Woods, W. G., Ogder, A., Weinstein, H., Sheperd, L., Rowe, J. M., and Wierznik, P. M. (1995) Phase III randomized study of all-trans retoinoic acid Vs Daunorubicin and Ara-C as induction therapy, 10 patients with previously untreated APL. Blood 86 (Suppl.), 125a
55. Eardley, A. M., Heller, G., and Warrell, R. P. (1994) Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocyitic leukemia. Leukemia 8, 934-939.
56. Frankel, S. R., Eardley, A., Lauwers, G., Weiss, M., and Warrell, R. (1992) The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann. Int. Med. 117, 292-296
57. Ohno, R., Yoshida, H., and Fukutani, H. (1993) Multi-institutional study of all-trans retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukemia 7, 1722-1727
58. Dombret, H., Scrobohaci, M. L., Ghorra, P., Zini, J. M., Daniel, M. T., Castaigne, S., and Degos, L. (1993) Coagulation disorders associated with acute promyelocytic leukemia: Corrective effect of all-trans retinoic acid treatment. Leukemia 7, 2-9
59. Runde, V., Aul, C., Sudhoff, T., Heyll, A., and Schneider, W. (1993) Retinoic acid in the treatment of acute promyelocytic leukemia: Inefficacy of the 13-cis isomer and induction of complete remission by the all-trans isomer complicated by thromboembolic events. Ann. Hematol. 64, 270-272
60. Huang, W., Sun, G. L., Li, X. S., Cao, Q., Lu, Y., Jang, G. S., Zhang, F Q., Chai, J. R., Wang, Z. Y., and Waxman, S. (1993) Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood 82, 1264-1269
61. Vadhat, L., Maslak, P., Miller, W. H., Eardley, A., Heller, G., Scheinberg, D. A., and Warrell, R. P. (1994) Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia. Impact of leucocytosis, low dose chemotherapy, PML-RARα isoform and CDB expression in patients treated with all-trans retinoic acid. Blood 84, 3843-3849
62. Fukutani, H., Naoe, T., Ohno, R., Yoshida, H., Kiyooi, H., Miyawaki, S., Morishita, H., Sano, F., Kmibayashi, H., and Matsue, K. (1995) Prognostic significance of the RT-PCR assay of PML-RARα transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho). Leukemia 9, 588-593
63. Chomienne, C. (1995) RT-PCR in acute promyelocylic leukemia. Second Workshop of the European Retinoic Group, Paris, France, December 17-18, 1994. Leukemia 10, 368-371
64. Adamson, P. C., Boylan, J. F., Balis, F. M., Murphy, R. F., Godwin, K. A., Cudas, L. J., and Poplack, D. G. (1993) Time course of induction of metabolism of all trans retinoic acid and the up regulation of cellular retinoic acid binding protein. Cancer Res 53, 472-476
65. Rigas, J. R., Francis, P. A., Muindi, J. R. F., Kris, M. G., Huselton, C., DeGrazia, F., Orazem, J. P., Young, C. W., and Warrell, R. P. (1993) Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid and its modulation by ketoconazole. J. Natl. Cancer Inst. 85, 1921-1926
66. Miller, W. H., Jakubowski A., Tong, W. A., Miller, V. A., Rigas, J. R., Bendetti, F., Gill, G. M., Truglia, J. A., Ulm, E., Shirley, M., and Warrell, R. P. (1995). 9-cis Retinoic acid induces complete remission, but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 85, 3021-3027
67. Tukeshita, A., Shibata, Y., Shinjo, K., Yanagi, M., Tobita, T., Ohnishi, K., Miyawaki, S., Shudo, K., and Ohno, R (1996) Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinnid, Am80. Ann. Int. Med. 124, 893-896